Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulphate for prevention of intraocular pressure rise during rapid sequence induction
PACTR201701001958143Recruiting
- Sponsor
- Fayoum University Hospital
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of magnesium sulfate in ocular hypertension (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Intraocular pressure. Started Feb 2017; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on PACTR201701001958143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201701001958143.